Results 91 to 100 of about 9,982 (193)

Experience with Lipofilling in Children with Localized Scleroderma: Case Study

Вопросы современной педиатрии
Background. Localized scleroderma (LS) is an inflammatory sclerosing disease of unknown etiology. It is characterized by progressive lesion of connective tissue leading to sclerosis and/or atrophy of the skin and underlying tissues.
Alina R. Misbakhova, Nataliya E. Manturova, Larisa S. Kruglova, Nikolay N. Murashkin, Sofiya R. Mayransaeva   +4 more
doaj   +1 more source

Elevated Serum BAFF Levels in Patients with Localized Scleroderma in contrast to other organ-specific autoimmune diseases

, 2007
Serum levels of B-cell activating factor belonging to the tumor necrosis factor family (BAFF), a potent B-cell survival factor, are elevated in patients with systemic autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis ...
45413, Takehara, Kazuhiko, 45412, 20168, 45414, 45411, 45410, 50142253, Hasegawa, Minoru, Matsushita, Yukiyo, 20219, Sato, Shinichi, Horikawa, Mayuka, 60432126, Ogawa, Fumihide, 143, 50283130, 304, Wayaku, Takamasa, Matsushita, Takashi, Echigo, Takeshi, 20215792   +21 more
core   +1 more source

Congenital localized scleroderma

Objectives Juvenile localized scleroderma (JLS) usually has its onset during later childhood. This report describes the clinical and serologic features of six children with congenital localized scleroderma (CLS).
Zulian , F.
core  

Pirfenidone gel in patients with localized scleroderma: a phase II study

, 2014
Introduction: Localized scleroderma is an inflammatory disease in its first stages and a fibrotic process in later stages, principally mediated by the transforming growth factor ?. To date, there is no standard treatment.
Guevara-Gutierrez, E, Sergio Sánchez-Enríquez, Marco Rodríguez-Castellanos, Rodriguez-Castellanos, M, Tlacuilo-Parra, A, Velez-Gomez, E, Velez-Gomez, E., Rodriguez-Castellanos, M., Tlacuilo-Parra, A., Ezequiel Vélez-Gómez, Alberto Tlacuilo-Parra, Guevara-Gutierrez, E., Elizabeth Guevara-Gutiérrez, Sanchez-Enriquez, S., Sanchez-Enriquez, S   +14 more
core   +1 more source

Localized scleroderma is an autoimmune disorder

Objectives. There have been many studies suggesting that localized scleroderma has a strong autoimmune background, although the lesions are usually limited to the skin and subcutaneous tissue.
Takehara, Kazuhiko, Sato, Shinichi
core  

Prevalence of localized scleroderma in the Krasnodar territory

, 2017
The authors conducted a study of particular features of the course of localized scleroderma in the south of Russia (Krasnodar territory). 65 case histories were analyzed.
N. V. Sorokina, M. M. Tlish
core   +1 more source

Localized scleroderma in a 12-year-old girl presenting as gingival recession. A case report and literature review.

, 2001
Scleroderma is a connective tissue disorder that displays considerable clinical heterogeneity. This case describes a 12-year-old girl who presented with a localized form of the disease.
Shaw, L., Roberts, Anthony, Baxter, A. M., Roberts, A., Chapple, I. L., Chapple, Iain; id_orcid, Shaw, Linda, Baxter, Alexander   +7 more
core   +2 more sources

Localized scleroderma: case report and literature review.

Background. Localized scleroderma is a rare chronic autoimmune inflammatory disorder, belonging to the spectrum of sclerosing skin diseases, affecting patients of any age, more frequently Caucasian females.
Pargaliauskaitė, Julija,
core  

Connective tissue nevus misdiagnosed as juvenile localized scleroderma. [PDF]

Pediatr Rheumatol Online J, 2023
Tirelli F, Giraudo C, Soliani M, Calabrese F, Martini G, Gisondi P, Meneghel A, Zulian F.   +7 more
europepmc   +1 more source

Longstanding epileptic encephalopathy and linear localized scleroderma: Two distinct pathologic processes in an adolescent

, 2008
We report a 7-year-old boy who unexpectedly developed a multi-drug resistant epilepsy with negative neuroimaging results, followed by the insidious appearance of linear localized scleroderma involving the right leg.
Contaldo I., Battaglia D., Bersani G., Rigante D.   +3 more
core   +1 more source